Home › Blasenkanker › Californië › San Francisco
Blasenkanker klinische studies in San Francisco, CA
13 studies voor Blasenkanker zoeken deelnemers op locaties in en rond San Francisco (binnen ongeveer 30 mijl). Open een studie om te zien wie er kan deelnemen en hoe je contact opneemt met het studieteam.
Officiële studietekst (Engels)
Rekruteren voor een studie? Laat deze bovenaan deze pagina verschijnen — $99 voor 30 dagen →
KEYMAKER-U04 Substudy 04D: A Clinical Study of New Treatments Given With Enfortumab Vedotin and Pembrolizumab in People With Urothelial Cancer (MK-3475-04D/KEYMAKER-U04)
RekruterenFase 1/2
- UCSF Medical Center at Mission Bay ( Site 5044), San Francisco
Imaging Study of [89Zr]DFO-YS5 for Cancer Detection
RekruterenFase 1
- University of California, San Francisco, San Francisco
Enfortumab Vedotin and Pembrolizumab Combined With Radiotherapy in Muscle Invasive Bladder Cancer
RekruterenFase 1/2
- University of California, San Francisco, San Francisco
A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
RekruterenFase 3
- UCSF Medical Center at Mission Bay, San Francisco
A Study Evaluating the Safety, Efficacy, and Pharmacokinetics (PK) of EVOLVE104 in Participants With Advanced Urothelial and Squamous Cell Carcinomas
RekruterenFase 1
- UCSF Medical center Parnassus, San Francisco
Phase 2/3 Trial of Izalontamab Brengitecan vs Platinum-based Chemotherapy for Metastatic Urothelial Cancer With Disease Progression on or After Immunotherapy
RekruterenFase 2/3
- Pacific Hematology Oncology Associates, San Francisco
A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations
RekruterenFase 2
- UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco
An Open-label Study to Investigate the Efficacy and Safety of Dato-DXd + Rilvegostomig vs SoC in Adult Participants With High-risk MIUC
RekruterenFase 3
- Research Site, San Francisco
A Study of Disitamab Vedotin Alone or With Pembrolizumab in Urothelial Cancer That Expresses HER2
RekruterenFase 2
- UCSF Cancer Center MZ Phlebotomy, San Francisco
- UCSF Mount Zion Phlebotomy, San Francisco
- UCSF Parnassus Phlebotomy, San Francisco
- en nog 3
Predicting BCG Response
RekruterenObservatieonderzoek
- UCSF, San Francisco
A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation
RekruterenFase 1
- University of California San Francisco, San Francisco
Blue Light Cystoscopy With Cysview® Registry
RekruterenObservatieonderzoek
- University of California, San Francisco, San Francisco
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
RekruterenObservatieonderzoek
- Massive Bio SYNERGY-AI site, San Francisco
Blasenkanker studies in andere steden
- New York City, NY35 studies
- Nashville, TN31 studies
- Houston, TX31 studies
- Dallas, TX27 studies
- Boston, MA26 studies
- Washington, DC26 studies
- Los Angeles, CA24 studies
- Baltimore, MD24 studies
- St. Louis, MO22 studies
- Philadelphia, PA21 studies
- Seattle, WA21 studies
- Edison, NJ21 studies
Andere studies in San Francisco
- Prostaatkanker45 studies
- Borstkanker43 studies
- Niet-kleincellige longkanker36 studies
- Kanker (alle vormen)35 studies
- Hartfalen29 studies
- Metastatische kanker28 studies
- Longkanker23 studies
- Melanoom22 studies
- Aldermeesklierkanker20 studies
- Eierstokkanker19 studies
- Colorectale kanker18 studies
- Cardiovasculaire ziekte18 studies
Van ClinicalTrials.gov, gegevens opgehaald op 5 okt. 2026. Elke studie stelt eigen deelnamecriteria vast; het studieteam bepaalt wie er kan deelnemen.